NCT04967625 2021-07-28
A Phase II Study of Sintilimab Combined With Anlotinib in Treatment of ED-SCLC
Zhejiang Cancer Hospital
Phase 2 Unknown
Clinical Trials
3 trialsNCT03253068 2020-05-19
Pembrolizumab Plus Amurubicin in Patients With Refractory Small-cell Lung Cancer
Wakayama Medical University
Phase 2 Unknown
NCT02179528 2014-09-12
Study of Small Doses of Etoposide as Maintenance Treatment in Small Cell Lung Cancer(SCLC)
Peking University Cancer Hospital & Institute
Phase 2 Unknown